| Daniel Lee Webber, RPH | |
|
3107 Lurleen B Wallace Blvd, Northport, AL 35476-3256 | |
| (205) 333-9343 | |
| (205) 333-1544 |
| Full Name | Daniel Lee Webber |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3107 Lurleen B Wallace Blvd, Northport, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013528652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 12229 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Lee Webber, RPH 3107 Lurleen B Wallace Blvd, Northport, AL 35476-3256 Ph: (205) 333-9343 | Daniel Lee Webber, RPH 3107 Lurleen B Wallace Blvd, Northport, AL 35476-3256 Ph: (205) 333-9343 |
News Archive
Scientists at the University of California, San Diego have identified a previously unknown kinase that regulates cell proliferation, shape and migration, and may play a major role in the progression or metastasis of cancer cells.
Cardiff County Court has today awarded a guaranteed £350,000 compensation, with the possibility of further interest, to UNISON member Alison Dugmore (37), who developed a life-threatening allergy to latex while working at two hospitals in Swansea.
Brain imaging of pathological tau-protein "tangles" reliably predicts the location of future brain atrophy in Alzheimer's patients a year or more in advance, according to a new study by scientists at the UC San Francisco Memory and Aging Center. In contrast, the location of amyloid "plaques," which have been the focus of Alzheimer's research and drug development for decades, was found to be of little utility in predicting how damage would unfold as the disease progressed.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
› Verified 3 days ago
Dr. Jessica Jo Salvatore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5710 Mcfarland Blvd, Northport, AL 35476 Phone: 205-333-7873 | |
Nicholas Matthew Witucki, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Casey Rasinen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Dr. Zachary Grant Hunt, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Jann Sides, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Mcfarland Blvd, Northport, AL 35476 Phone: 205-339-0155 Fax: 205-339-1316 | |
Dr. Robert Meaders Bragg, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 Mcfarland Blvd, Northport, AL 35476 Phone: 205-339-2700 |